Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us

ML-099

  • Zoom
    ML-<wbr/>099
  • ML-<wbr/>099
Cat No: 15176
Biochemicals - Small Molecule Activators
Cayman

ML-099 is a small molecule pan activator of Ras-related GTPases, activating Rac1, cell division cycle 42, Ras, and Rab-2A with EC50 values of 20, 100, 141, and 355 nM, respectively.{24525}

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • 2-[(2-phenylethyl)thio]-3-pyridinecarboxylic acid
Correlated keywords:
  • cancers signals transductions intracellulars signaling pan activators Ras-related Ras GTPases activating activates activators Rab-2A Rab2A Rabs 2A cdc42 cdc-42 cdcs 42 cells divisions cycles Rac1 Rac-1 Racs 1 one ML-099 MLs 099 ML099 ML99 ML-99 99 CIDs 888706 CID888706 CID-888706
Product Overview:
ML-099 is a small molecule pan activator of Ras-related GTPases, activating Rac1, cell division cycle 42, Ras, and Rab-2A with EC50 values of 20, 100, 141, and 355 nM, respectively.{24525}
Size 1 mg
Shipping dry ice
CAS Number 496775-95-2
Molecular Formula C14H13NO2S
SMILES OC(C1=CC=CN=C1SCCC2=CC=CC=C2)=O
Molecular Weight 259,3
Formulation A crystalline solid
Purity ≥98%
Custom Code 2930.90
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : ML-<wbr/>099 There are 3 products.

Search